We next assessed the communication between the IGF1R and Src signaling pathways in NSCLC cell lines after treatment with linsitinib (1 μM), dasatinib (100 nM), or LL28 (1 μM) for 1 day. The gene discussed is IGF1R; the disease is non-small cell lung carcinoma.